Pulmonology Advisor

TRPC Channels May Reduce Endothelial Dysfunction in PAH

Transient receptor potential canonical channels are essential for maintaining the function of human pulmonary endothelial cells in PAH.

Nyrada’s Phase IIa Clinical Trial for Heart Attack Treatment Approved

Nyrada Inc. (ASX:NYR), a clinical-stage biotechnology company focused on developing Transient Receptor Potential Canonical ...
Science Daily

Breakthrough in drug-free pain relief: Solvent-mediated analgesia for safer, non-addictive pain management

Researchers have made a discovery regarding the TRPV1 (transient receptor potential vanilloid 1) ion channel and its role in pain perception. The study reveals how solvent molecules can modulate pain ...
Medscape

Is Oral XEN-D0501 the Next Obesity Drug Hype?

XEN-D0501, a transient receptor potential vanilloid 1 (TRPV1) antagonist, is gaining attention for its potential as an oral tablet to treat type 2 diabetes, obesity, and cardiovascular diseases. Dorte ...